Suppression of MALT1 protease activity with small molecule inhibitors showed promising efficacies in subtypes of B cell lymphoma and improvement in experimental autoimmune encephalomyelitis model. The gene discussed is MALT1; the disease is experimental autoimmune encephalomyelitis.